1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ITERUM THERAPEUTICS PLC
Iterum Therapeutics Plc
XNAS: ITRMF

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Iterum Therapeutics PLC is on 13 May 2026 for the purpose of Iterum Therapeutics PLC First Quarter Earnings Results for 2026 See details


Insider Trading disclosures for Iterum Therapeutics PLC

The latest disclosure was made by Michael W. Dunne in Iterum Therapeutics PLC where a trade of 6,000 Ordinary Shares done at an average price of $0.4 was reported to US exchanges on Nov. 18, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Michael W. Dunne Director Purchase of securities on an exchange or from another person at price $ 0.37 per share. 18 Nov 2025 6,000 241,001 (1%) 0% 0.4 2,191 Ordinary Shares
Michael W. Dunne Director Purchase of securities on an exchange or from another person at price $ 0.72 per share. 08 Aug 2025 15,000 235,001 (1%) 0% 0.7 10,854 Ordinary Shares
Christine Coyne Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2025 200,000 200,000 - - Share Option (Right to Buy)
Ronald M. Hunt Director 06 Aug 2024 65,481 65,481 - - Warrants (right to buy)
Ronald M. Hunt Director 06 Aug 2024 182,453 253,898 (1%) 1% - Ordinary Shares
Ronald M. Hunt Director 06 Aug 2024 65,481 91,122 (0%) 0% - Ordinary Shares
Ronald M. Hunt Director 06 Aug 2024 364,906 0 - - Subscription Rights (right to buy)
Ronald M. Hunt Director 06 Aug 2024 182,453 182,453 - - Warrants (right to buy)
Ronald M. Hunt Director 06 Aug 2024 182,453 182,453 - - Warrants (right to buy)
Ronald M. Hunt Director 06 Aug 2024 130,962 0 - - Subscription Rights (right to buy)
Ronald M. Hunt Director 06 Aug 2024 65,481 65,481 - - Warrants (right to buy)
Corey N. Fishman Director, Chief Executive Officer 06 Aug 2024 82,613 82,613 - - Warrants (right to buy)
Corey N. Fishman Director, Chief Executive Officer 06 Aug 2024 82,613 137,062 (0%) 0% - Ordinary Shares
Corey N. Fishman Director, Chief Executive Officer 06 Aug 2024 165,226 0 - - Subscription Rights (right to buy)
Corey N. Fishman Director, Chief Executive Officer 06 Aug 2024 82,613 82,613 - - Warrants (right to buy)
Michael W. Dunne Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2024 106,247 220,001 (1%) 0% - Ordinary Shares
Michael W. Dunne Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2024 212,494 0 - - Subscription Rights (right to buy)
Michael W. Dunne Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2024 106,247 106,247 - - Warrants (right to buy)
Michael W. Dunne Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2024 106,247 106,247 - - Warrants (right to buy)
Michael Dunne W. Director Purchase of securities on an exchange or from another person at price $ 1.40 per share. 22 Dec 2023 25,000 113,754 (0%) 0% 1.4 35,000 Ordinary Shares
W. Dunne Michael Director Purchase of securities on an exchange or from another person at price $ 1.84 per share. 18 Dec 2023 10,000 88,754 (0%) 0% 1.8 18,442 Ordinary Shares
Sailaja Puttagunta Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2023 8,333 16,666 - - Restricted Share Units
Puttagunta Sailaja Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.12 per share. 01 Dec 2023 2,933 10,369 (0%) 0% 2.1 6,218 Ordinary Shares
Puttagunta Sailaja Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2023 8,333 13,302 (0%) 0% 0 Ordinary Shares
Ronald M. Hunt Director 01 Jul 2023 2,796 8,867 (0%) 0% - Ordinary Shares
Ronald M. Hunt Director 01 Jul 2023 2,796 0 - - Restricted Share Units
Michael W. Dunne Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2023 1,779 0 - - Restricted Share Units
Michael W. Dunne Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2023 1,779 55,267 (0%) 0% - Ordinary Shares
Michael W. Dunne Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2023 15,853 0 - - Restricted Share Units
Michael W. Dunne Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2023 15,853 53,488 (0%) 0% 0 Ordinary Shares
Beth P. Hecht Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2023 15,853 18,839 (0%) 0% 0 Ordinary Shares
Beth P. Hecht Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2023 15,853 0 - - Restricted Share Units
Mark Chin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2023 15,853 0 - - Restricted Share Units
Mark Chin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2023 15,853 18,306 (0%) 0% 0 Ordinary Shares
Ronald M. Hunt Director 01 Apr 2023 2,041 0 - - Restricted Share Units
Ronald M. Hunt Director 01 Apr 2023 2,041 6,071 (0%) 0% 0 Ordinary Shares
Michael W. Dunne Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2023 1,299 37,635 (0%) 0% 0 Ordinary Shares
Corey N. Fishman Director, Chief Executive Officer 31 Mar 2023 275,000 275,000 - - Stock Option (Right to Buy)
Judith M. Matthews Chief Financial Officer 31 Mar 2023 100,000 100,000 - - Stock Option (Right to Buy)
Sailaja Puttagunta Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2023 75,000 75,000 - - Stock Option (Right to Buy)
Corey N. Fishman Director, Chief Executive Officer 11 Mar 2023 14,333 50,132 (0%) 0% 0 Ordinary Shares
Corey N. Fishman Director, Chief Executive Officer 11 Mar 2023 14,333 0 - - Restricted Share Units
Corey N. Fishman Director, Chief Executive Officer 11 Mar 2023 5,683 44,449 (0%) 0% 1.0 5,456 Ordinary Shares
Judith M. Matthews Chief Financial Officer 11 Mar 2023 6,666 0 - - Restricted Share Units
Judith M. Matthews Chief Financial Officer 11 Mar 2023 2,883 8,135 (0%) 0% 1.0 2,768 Ordinary Shares
Judith M. Matthews Chief Financial Officer 11 Mar 2023 6,666 11,018 (0%) 0% 0 Ordinary Shares
Ronald M. Hunt Director 01 Jan 2023 1,197 0 - - Restricted Share Units
Ronald M. Hunt Director 01 Jan 2023 1,197 4,030 (0%) 0% - Ordinary Shares
Michael W. Dunne Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2023 761 36,337 (0%) 0% - Ordinary Shares
Michael W. Dunne Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2023 761 0 - - Restricted Share Units
Brenton K. Ahrens Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2022 29,125 29,125 - - Stock Option (Right to Buy)
Ronald M. Hunt Director 23 Dec 2022 5,479 5,479 - - Restricted Share Units
Michael W. Dunne Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2022 3,487 3,487 - - Restricted Share Units
Sailaja Puttagunta Chief Medical Officer Sale of securities on an exchange or to another person at price $ 1.32 per share. 01 Dec 2022 3,365 4,969 (0%) 0% 1.3 4,442 Ordinary Shares
Sailaja Puttagunta Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2022 8,334 8,334 (0%) 0% 0 Ordinary Shares
Sailaja Puttagunta Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2022 8,334 24,999 - - Restricted Share Units
Brenton K. Ahrens Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Sep 2022 14,838 14,838 - - Stock Option (Right to Buy)
Ronald M. Hunt Director 25 Sep 2022 2,796 2,796 - - Restricted Share Units
Michael W. Dunne Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Sep 2022 1,779 1,779 - - Restricted Share Units
Brenton K. Ahrens Director Sale of securities on an exchange or to another person at price $ 1.78 per share. 16 Sep 2022 7,246 0 (0%) 0% 1.8 12,910 Ordinary Shares
Brenton K. Ahrens Director Sale of securities on an exchange or to another person at price $ 1.90 per share. 16 Sep 2022 15,000 22,246 (0%) 0% 1.9 28,542 Ordinary Shares
Brenton K. Ahrens Director Sale of securities on an exchange or to another person at price $ 1.77 per share. 16 Sep 2022 15,000 7,246 (0%) 0% 1.8 26,478 Ordinary Shares
Brenton K. Ahrens Director Sale of securities on an exchange or to another person at price $ 2.14 per share. 13 Sep 2022 15,000 67,246 (0%) 0% 2.1 32,118 Ordinary Shares
Brenton K. Ahrens Director Sale of securities on an exchange or to another person at price $ 2.02 per share. 13 Sep 2022 15,000 37,246 (0%) 0% 2.0 30,272 Ordinary Shares
Brenton K. Ahrens Director Sale of securities on an exchange or to another person at price $ 2.10 per share. 13 Sep 2022 15,000 52,246 (0%) 0% 2.1 31,457 Ordinary Shares
Brenton K. Ahrens Director Sale of securities on an exchange or to another person at price $ 2.32 per share. 08 Sep 2022 15,000 97,246 (0%) 0% 2.3 34,730 Ordinary Shares
Brenton K. Ahrens Director Sale of securities on an exchange or to another person at price $ 2.26 per share. 08 Sep 2022 3,298 112,246 (0%) 0% 2.3 7,465 Ordinary Shares
Brenton K. Ahrens Director Sale of securities on an exchange or to another person at price $ 2.31 per share. 08 Sep 2022 15,000 82,246 (0%) 0% 2.3 34,608 Ordinary Shares
Brenton K. Ahrens Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2022 113,276 113,276 - - Stock Option (Right to Buy)
Ronald M. Hunt Director 25 Jun 2022 30,623 30,623 - - Restricted Share Units
Michael W. Dunne Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2022 19,488 19,488 - - Restricted Share Units
Ronald M. Hunt Director 23 Jun 2022 36,798 42,501 (0%) 0% - Ordinary Shares
Ronald M. Hunt Director 23 Jun 2022 36,798 0 - - Restricted Share Units
Michael W. Dunne Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Jun 2022 36,798 0 - - Restricted Share Units
Michael W. Dunne Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Jun 2022 36,798 383,647 (2%) 0% - Ordinary Shares
Beth P. Hecht Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Jun 2022 36,798 0 - - Restricted Share Units
Beth P. Hecht Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Jun 2022 36,798 44,805 (0%) 0% 0 Ordinary Shares
Mark Chin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Jun 2022 36,798 36,798 (0%) 0% - Ordinary Shares
Mark Chin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Jun 2022 36,798 0 - - Restricted Share Units
Brenton K. Ahrens Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 647,059 647,059 - - Share Option (Right to Buy)
Ronald M. Hunt Director 15 Jun 2022 647,059 647,059 - - Share Option (Right to Buy)
Michael W. Dunne Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 237,795 237,795 - - Restricted Share Units
David George Kelly Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 647,059 647,059 - - Share Option (Right to Buy)
Beth P. Hecht Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 237,795 237,795 - - Restricted Share Units
Mark Chin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 237,795 237,795 - - Restricted Share Units
Brenton K. Ahrens Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2022 47,436 47,436 - - Stock Option (Right to Buy)
Ronald M. Hunt Director 25 Mar 2022 17,955 17,955 - - Restricted Share Units
Michael W. Dunne Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2022 11,426 11,426 - - Restricted Share Units
Michael W. Dunne Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Mar 2022 10,494 0 - - Restricted Share Units
Michael W. Dunne Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Mar 2022 10,494 346,849 (2%) 0% 0 Ordinary Shares
Beth P. Hecht Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Mar 2022 7,642 8,007 (0%) 0% 0 Ordinary Shares
Beth P. Hecht Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Mar 2022 7,642 0 - - Restricted Share Units
Corey N. Fishman Director, Chief Executive Officer 11 Mar 2022 215,000 215,000 - - Restricted Share Units
Corey N. Fishman Director, Chief Executive Officer 11 Mar 2022 215,000 537,008 (3%) 1% - Ordinary Shares
Judith M. Matthews Chief Financial Officer 11 Mar 2022 63,340 65,292 (0%) 0% 0.3 19,635 Ordinary Shares
Michael W. Dunne Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jul 2021 80,000 336,355 (2%) 0% 0 Ordinary Shares
Brenton K. Ahrens Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2021 64,706 64,706 - - Stock Option (Right to Buy)
Ronald M. Hunt Director 23 Jun 2021 36,798 36,798 - - Restricted Stock Units
Corey N. Fishman Director, Chief Executive Officer 23 Jun 2021 5,280,000 5,280,000 - - Stock Option (Right to Buy)
Michael W. Dunne Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2021 36,798 36,798 - - Restricted Stock Units
David George Kelly Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2021 64,706 64,706 - - Stock Option (Right to Buy)
Beth P. Hecht Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2021 36,798 36,798 - - Restricted Stock Units
Judith M. Matthews Chief Financial Officer 23 Jun 2021 1,936,000 1,936,000 - - Stock Option (Right to Buy)
Mark Chin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2021 36,798 36,798 - - Restricted Stock Units
Michael W. Dunne Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 10,494 10,494 - - Restricted Stock Units
Beth P. Hecht Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2021 7,642 7,642 - - Restricted Stock Units
Corey N. Fishman Director, President & CEO 11 Mar 2021 430,000 430,000 - - Restricted Share Units
Judith M. Matthews Chief Financial Officer 11 Mar 2021 200,000 200,000 - - Restricted Share Units
Corey N. Fishman Director, President & CEO 25 Jan 2021 85,445 322,008 (2%) 0% 1.7 147,820 Ordinary Shares
Corey N. Fishman Director, President & CEO 25 Jan 2021 167,500 407,453 (2%) 1% 0 Ordinary Shares
Michael W. Dunne Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2021 80,000 289,498 (1%) 0% 0 Ordinary Shares
Michael W. Dunne Director Sale of securities on an exchange or to another person at price $ 1.73 per share. 25 Jan 2021 33,143 256,355 (1%) 0% 1.7 57,337 Ordinary Shares
Judith M. Matthews Chief Financial Officer 25 Jan 2021 33,868 28,632 (0%) 0% 1.7 58,592 Ordinary Shares
Judith M. Matthews Chief Financial Officer 25 Jan 2021 62,500 62,500 (0%) 0% 0 Ordinary Shares
Michael W. Dunne Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Oct 2020 46,155 46,155 - - Warrants (right to buy)
Michael W. Dunne Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Oct 2020 61,540 209,498 (1%) 0% - Ordinary Shares
Judith M. Matthews Chief Financial Officer 30 Sep 2020 56,130 0 (0%) 0% 1.6 92,053 Ordinary Shares
Patrick J. Heron Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2020 2,852 0 - - Restricted Stock Units
Patrick J. Heron Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2020 2,852 9,006 (0%) 0% - Ordinary Shares
Ronald M. Hunt Director 01 Jul 2020 5,703 0 - - Restricted Stock Units
Ronald M. Hunt Director 01 Jul 2020 5,703 5,703 (0%) 0% - Ordinary Shares
Mark Chin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2020 5,703 0 - - Restricted Stock Units
Mark Chin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2020 5,703 11,857 (0%) 0% - Ordinary Shares
David George Kelly Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jun 2020 11,406 0 - - Restricted Stock Units
David George Kelly Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jun 2020 11,406 37,108 (0%) 0% - Ordinary Shares
David George Kelly Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2020 62,840 62,840 - - Stock Option (Right to Buy)
Mark Chin Director Other type of transaction at price $ 0.00 per share. 07 Apr 2020 1,089,903 0 (0%) 7% - Ordinary Shares
James I. Healy Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 5,703 5,703 - - Restricted Stock Units
Brenton K. Ahrens None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 19,671 19,671 - - Stock Option (Right to Buy)
Patrick J. Heron Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 2,852 2,852 - - Restricted Stock Units
Patrick J. Heron Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 9,836 9,836 - - Stock Option (Right to Buy)
Shahzad Malik None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 19,671 19,671 - - Stock Option (Right to Buy)
Ronald M. Hunt Director, Ten Percent Owner 13 Jun 2019 5,703 5,703 - - Restricted Stock Units
David George Kelly None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 11,406 11,406 - - Restricted Stock Units
Mark Chin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 5,703 5,703 - - Restricted Stock Units
James I. Healy Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 May 2019 6,154 0 - - Restricted Stock Units
James I. Healy Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 May 2019 6,154 6,154 (0%) 0% - Ordinary Shares
Paul R. Edick None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 May 2019 6,154 31,390 (0%) 0% - Ordinary Shares
Paul R. Edick None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 May 2019 6,154 0 - - Restricted Stock Units
Mark Chin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 May 2019 6,154 6,154 (0%) 0% - Ordinary Shares
Mark Chin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 May 2019 6,154 0 - - Restricted Stock Units
Corey N. Fishman Director, President & CEO 15 Feb 2019 150,000 150,000 - - Stock Option (Right to Buy)
Michael W. Dunne Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2019 85,000 85,000 - - Stock Option (Right to Buy)
Judith M. Matthews Chief Financial Officer 15 Feb 2019 30,000 30,000 - - Stock Option (Right to Buy)
David George Kelly None Purchase of securities on an exchange or from another person at price $ 6.29 per share. 30 Nov 2018 10,000 19,548 (0%) 0% 6.3 62,887 Ordinary Shares
Mark Chin None Purchase of securities on an exchange or from another person at price $ 6.10 per share. 30 Oct 2018 58,000 1,089,903 (7%) 0% 6.1 353,800 Ordinary Shares
Michael W. Dunne Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 10.00 per share. 04 Sep 2018 500 147,958 (1%) 0% 10 5,000 Ordinary Shares
Michael W. Dunne Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 10.00 per share. 24 Aug 2018 500 146,958 (1%) 0% 10 5,000 Ordinary Shares
Michael W. Dunne Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 10.00 per share. 24 Aug 2018 500 147,458 (1%) 0% 10 5,000 Ordinary Shares
Paul R. Edick None Purchase of securities on an exchange or from another person at price $ 10.44 per share. 23 Aug 2018 500 25,236 (0%) 0% 10.4 5,219 Ordinary Shares
Corey N. Fishman Director, President & CEO 17 Aug 2018 2,000 239,953 (1%) 0% 8.7 17,466 Ordinary Shares
James I. Healy Director, Ten Percent Owner 30 May 2018 721,408 721,408 (5%) 5% 0 Ordinary Shares
James I. Healy Director, Ten Percent Owner 30 May 2018 275,446 0 - - Series B-1 Preferred Shares
James I. Healy Director, Ten Percent Owner 30 May 2018 721,408 0 - - Series A Preferred Shares
James I. Healy Director, Ten Percent Owner 30 May 2018 275,446 996,854 (7%) 1% 0 Ordinary Shares
James I. Healy Director, Ten Percent Owner 30 May 2018 229,660 1,226,514 (8%) 1% 0 Ordinary Shares
James I. Healy Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 13.00 per share. 30 May 2018 500,000 1,726,514 (12%) 3% 13 6,500,000 Ordinary Shares
James I. Healy Director, Ten Percent Owner 30 May 2018 229,660 0 - - Series B-2 Preferred Shares
Brenton K. Ahrens None 30 May 2018 721,408 721,408 (5%) 5% 0 Ordinary Shares
Brenton K. Ahrens None 30 May 2018 275,446 996,854 (7%) 1% 0 Ordinary Shares
Brenton K. Ahrens None 30 May 2018 229,660 1,226,514 (8%) 1% 0 Ordinary Shares
Brenton K. Ahrens None Purchase of securities on an exchange or from another person at price $ 13.00 per share. 30 May 2018 506,656 1,733,170 (12%) 3% 13 6,586,528 Ordinary Shares
Brenton K. Ahrens None 30 May 2018 229,660 0 - - Series B-2 Preferred Shares
Brenton K. Ahrens None 30 May 2018 275,446 0 - - Series B-1 Preferred Shares
Brenton K. Ahrens None 30 May 2018 721,408 0 - - Series A Preferred Shares
Patrick J. Heron Director, Ten Percent Owner 30 May 2018 53,899 0 - - Series B-1 Preferred Shares
Patrick J. Heron Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 13.00 per share. 30 May 2018 101,150 341,155 (2%) 0% 13 1,314,950 Ordinary Shares
Patrick J. Heron Director, Ten Percent Owner 30 May 2018 44,940 240,005 (1%) 0% 0 Ordinary Shares
Patrick J. Heron Director, Ten Percent Owner 30 May 2018 53,899 195,065 (1%) 0% 0 Ordinary Shares
Patrick J. Heron Director, Ten Percent Owner 30 May 2018 141,166 141,166 (1%) 1% 0 Ordinary Shares
Patrick J. Heron Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 13.00 per share. 30 May 2018 354,949 1,197,161 (8%) 2% 13 4,614,337 Ordinary Shares
Patrick J. Heron Director, Ten Percent Owner 30 May 2018 157,701 842,212 (6%) 1% 0 Ordinary Shares
Patrick J. Heron Director, Ten Percent Owner 30 May 2018 189,141 684,511 (4%) 1% 0 Ordinary Shares
Patrick J. Heron Director, Ten Percent Owner 30 May 2018 495,370 495,370 (3%) 3% 0 Ordinary Shares
Patrick J. Heron Director, Ten Percent Owner 30 May 2018 44,940 0 - - Series B-2 Preferred Shares
Patrick J. Heron Director, Ten Percent Owner 30 May 2018 495,370 0 - - Series A Preferred Shares
Patrick J. Heron Director, Ten Percent Owner 30 May 2018 189,141 0 - - Series B-1 Preferred Shares
Patrick J. Heron Director, Ten Percent Owner 30 May 2018 157,701 0 - - Series B-2 Preferred Shares
Patrick J. Heron Director, Ten Percent Owner 30 May 2018 141,166 0 - - Series A Preferred Shares
Shahzad Malik None 30 May 2018 218,338 609,485 (4%) 1% 0 Ordinary Shares
Shahzad Malik None 30 May 2018 391,147 391,147 (2%) 2% 0 Ordinary Shares
Shahzad Malik None Purchase of securities on an exchange or from another person at price $ 13.00 per share. 30 May 2018 8,144 29,836 (0%) 0% 13 105,872 Ordinary Shares
Shahzad Malik None 30 May 2018 7,771 21,692 (0%) 0% 0 Ordinary Shares
Shahzad Malik None 30 May 2018 13,921 13,921 (0%) 0% 0 Ordinary Shares
Shahzad Malik None 30 May 2018 13,921 0 - - Series B-1 Preferred Shares
Shahzad Malik None 30 May 2018 391,147 0 - - Series B-1 Preferred Shares
Shahzad Malik None 30 May 2018 7,771 0 - - Series B-2 Preferred Shares
Shahzad Malik None 30 May 2018 218,338 0 - - Series B-2 Preferred Shares
Shahzad Malik None Purchase of securities on an exchange or from another person at price $ 13.00 per share. 30 May 2018 228,840 838,325 (6%) 1% 13 2,974,920 Ordinary Shares
Ronald M. Hunt Director, Ten Percent Owner 30 May 2018 278,062 1,071,688 (7%) 1% 13 3,614,806 Ordinary Shares
Ronald M. Hunt Director, Ten Percent Owner 30 May 2018 466,793 0 - - Series A Preferred Shares
Ronald M. Hunt Director, Ten Percent Owner 30 May 2018 178,230 0 - - Series B-1 Preferred Shares
Ronald M. Hunt Director, Ten Percent Owner 30 May 2018 466,793 466,793 (3%) 3% 0 Ordinary Shares
Ronald M. Hunt Director, Ten Percent Owner 30 May 2018 178,230 645,023 (4%) 1% 0 Ordinary Shares
Ronald M. Hunt Director, Ten Percent Owner 30 May 2018 148,603 793,626 (5%) 1% 0 Ordinary Shares
Ronald M. Hunt Director, Ten Percent Owner 30 May 2018 148,603 0 - - Series B-2 Preferred Shares
Ronald M. Hunt Director, Ten Percent Owner 30 May 2018 384,615 384,615 (2%) 2% 13 4,999,995 Ordinary Shares
Paul R. Edick None 30 May 2018 1,591 24,736 (0%) 0% 0 Ordinary Shares
Paul R. Edick None 30 May 2018 1,591 0 - - Series B-2 Preferred Shares
Paul R. Edick None 30 May 2018 15,913 19,095 (0%) 0% 0 Ordinary Shares
Paul R. Edick None 30 May 2018 4,050 23,145 (0%) 0% 0 Ordinary Shares
Paul R. Edick None 30 May 2018 4,050 0 - - Series B-1 Preferred Shares
Paul R. Edick None 30 May 2018 15,913 0 - - Series A Preferred Shares
Corey N. Fishman Director, President & CEO 30 May 2018 3,000 237,953 (1%) 0% 13 39,000 Ordinary Shares
Corey N. Fishman Director, President & CEO 30 May 2018 33,259 0 - - Series A Preferred Shares
Corey N. Fishman Director, President & CEO 30 May 2018 4,050 0 - - Series B-1 Preferred Shares
Corey N. Fishman Director, President & CEO 30 May 2018 1,591 0 - - Series B-2 Preferred Shares
Corey N. Fishman Director, President & CEO 30 May 2018 1,591 234,953 (1%) 0% 0 Ordinary Shares
Corey N. Fishman Director, President & CEO 30 May 2018 4,050 233,362 (1%) 0% 0 Ordinary Shares
Corey N. Fishman Director, President & CEO 30 May 2018 33,259 229,312 (1%) 0% 0 Ordinary Shares
Michael W. Dunne Chief Scientific Officer 30 May 2018 2,917 0 - - Series B-2 Preferred Shares
Michael W. Dunne Chief Scientific Officer 30 May 2018 12,730 0 - - Series A Preferred Shares
Michael W. Dunne Chief Scientific Officer 30 May 2018 2,917 144,458 (1%) 0% 0 Ordinary Shares
Michael W. Dunne Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 13.00 per share. 30 May 2018 2,000 146,458 (1%) 0% 13 26,000 Ordinary Shares
Michael W. Dunne Chief Scientific Officer 30 May 2018 4,050 0 - - Series B-1 Preferred Shares
Michael W. Dunne Chief Scientific Officer 30 May 2018 4,050 141,541 (1%) 0% 0 Ordinary Shares
Michael W. Dunne Chief Scientific Officer 30 May 2018 12,730 137,491 (0%) 0% 0 Ordinary Shares
Vijay K. Lathi Ten Percent Owner 30 May 2018 148,603 0 - - Series B-2 Preferred Shares
Vijay K. Lathi Ten Percent Owner 30 May 2018 178,230 645,023 (4%) 1% 0 Ordinary Shares
Vijay K. Lathi Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 13.00 per share. 30 May 2018 278,062 1,071,688 (7%) 1% 13 3,614,806 Ordinary Shares
Vijay K. Lathi Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 13.00 per share. 30 May 2018 384,615 384,615 (2%) 2% 13 4,999,995 Ordinary Shares
Vijay K. Lathi Ten Percent Owner 30 May 2018 148,603 793,626 (5%) 1% 0 Ordinary Shares
Vijay K. Lathi Ten Percent Owner 30 May 2018 466,793 466,793 (3%) 3% 0 Ordinary Shares
Vijay K. Lathi Ten Percent Owner 30 May 2018 466,793 0 - - Series A Preferred Shares
Vijay K. Lathi Ten Percent Owner 30 May 2018 178,230 0 - - Series B-1 Preferred Shares
David George Kelly None 30 May 2018 9,548 0 - - Series A Preferred Shares
David George Kelly None 30 May 2018 9,548 9,548 (0%) 0% 0 Ordinary Shares
Judith M. Matthews Chief Financial Officer 30 May 2018 3,038 49,664 (0%) 0% 0 Ordinary Shares
Judith M. Matthews Chief Financial Officer 30 May 2018 10,980 46,626 (0%) 0% 0 Ordinary Shares
Judith M. Matthews Chief Financial Officer 30 May 2018 2,466 0 - - Series B-2 Preferred Shares
Judith M. Matthews Chief Financial Officer 30 May 2018 10,980 0 - - Series A Preferred Shares
Judith M. Matthews Chief Financial Officer 30 May 2018 3,038 0 - - Series B-1 Preferred Shares
Judith M. Matthews Chief Financial Officer 30 May 2018 4,000 56,130 (0%) 0% 13 52,000 Ordinary Shares
Judith M. Matthews Chief Financial Officer 30 May 2018 2,466 52,130 (0%) 0% 0 Ordinary Shares
Mark Chin None 30 May 2018 248,721 0 - - Series B-2 Preferred Shares
Mark Chin None Purchase of securities on an exchange or from another person at price $ 13.00 per share. 30 May 2018 337,606 1,031,903 (7%) 2% 13 4,388,878 Ordinary Shares
Mark Chin None 30 May 2018 248,721 694,297 (4%) 1% 0 Ordinary Shares
Mark Chin None 30 May 2018 445,576 445,576 (3%) 3% 0 Ordinary Shares
Mark Chin None 30 May 2018 445,576 0 - - Series B-1 Preferred Shares
James I. Healy Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2018 6,154 6,154 - - Restricted Stock Units
Brenton K. Ahrens None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2018 6,154 6,154 - - Restricted Stock Units
Patrick J. Heron Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2018 6,154 6,154 - - Restricted Stock Units
Shahzad Malik None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2018 11,241 11,241 - - Stock Option (Right to Buy)
Ronald M. Hunt Director, Ten Percent Owner 24 May 2018 11,241 11,241 - - Stock Option (Right to Buy)
Paul R. Edick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2018 6,154 6,154 - - Restricted Stock Units
Corey N. Fishman Director, President & CEO 24 May 2018 127,307 127,307 - - Stock Option (Right to Buy)
Michael W. Dunne Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2018 79,567 79,567 - - Stock Option (Right to Buy)
David George Kelly None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2018 6,154 6,154 - - Restricted Stock Units
Judith M. Matthews Chief Financial Officer 24 May 2018 23,870 23,870 - - Stock Option (Right to Buy)
Jeff Schaffnit Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2018 6,365 6,365 - - Stock Option (Right to Buy)
Jeff Schaffnit Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2018 25,461 25,461 - - Stock Option (Right to Buy)
Mark Chin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2018 6,154 6,154 - - Restricted Stock Units
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters